Efficacy of Nikkomycin Z for respiratory coccidioidomycosis in naturally infected dogs
dc.contributor.author | Shubitz, Lisa | |
dc.contributor.author | Roy, Michael E | |
dc.contributor.author | Nix, David | |
dc.contributor.author | Galgiani, John N. | |
dc.date.accessioned | 2016-11-30T16:45:33Z | |
dc.date.available | 2016-11-30T16:45:33Z | |
dc.date.issued | 2013-10 | |
dc.identifier.uri | http://hdl.handle.net/10150/621447 | |
dc.description | Nikkomycin Z (NikZ) is a chitin synthase inhibitor with antifungal efficacy against Coccidioides spp. and other endemic fungi. Dogs suffer a rate and range of natural coccidioidomycosis similar to humans and were considered an excellent model for initially testing NikZ against naturally acquired disease. Twelve dogs with coccidioidal pneumonia that had been present for an average of three months were treated with 250 mg (5 - 15 kg) or 500 mg (> 15 - 30 kg) twice daily for 60 days. Nine dogs completed the course of treatment and seven dogs had improvement in disease based on radiographs, clinicopathological parameters, physical examination findings, and subjective assessment by the owners; three dogs had resolution or near resolution of disease. Based on this small study, NikZ shows efficacy to treat naturally acquired coccidioidomycosis and merits further development for trials in humans. | en |
dc.language.iso | en_US | en |
dc.rights | Copyright © Arizona Board of Regents. | en |
dc.subject | Coccidioidomycosis | en |
dc.subject | Coccidioides immitis | en |
dc.subject | Coccidioides posadasii | en |
dc.subject | canine | en |
dc.subject | Dogs. | en |
dc.subject | Nikkomycin Z | en |
dc.subject | medication | en |
dc.title | Efficacy of Nikkomycin Z for respiratory coccidioidomycosis in naturally infected dogs | en_US |
dc.title.alternative | Data collection | en |
dc.type | Dataset | en |
dc.contributor.department | The University of Arizona | en |
dc.description.note | The datasets are divided into 6 groups. The data for the nine dogs that completed the study are shown in: Signalment, Enrollment Visit, Midpoint Visit, Pharmacokinetic Data, and End Visit. The information for the three dogs that did not complete the study is presented in Withdrawn Dogs. The results of the analysis were published: Shubitz, LF, Roy, ME, Nix, DE, et al. (2013). Efficacy of Nikkomycin Z for respiratory coccidioidomycosis in naturally infected dogs. Medical Mycology, 51, 747-754. | en |
dc.description.collectioninformation | This data is made available by the Valley Fever Center for Excellence and the University of Arizona Libraries. Questions or permission for re-use of content should be addressed to Lisa Shubitz, DVM at lfshubit@email.arizona.edu or 520-626-8198. | en |
refterms.dateFOA | 2018-04-20T04:26:13Z |